Download PDF
CC BY 4.0 · Pharmaceutical Fronts 2023; 05(03): e132-e140
DOI: 10.1055/s-0043-1774288
Original Article

Design, Synthesis, and Neuroprotective Effects of Novel Cinnamamide-Piperidine and Piperazine Derivatives

Jia-Yi Li   #
1   School of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
2   Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
,
Xin-Yan Peng   #
2   Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
,
Yi-Lei Huang
2   Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
,
Ling Jiang
2   Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
,
Jian-Qi Li
2   Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
,
Xue-Zhi Yang
3   Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China
,
Qing-Wei Zhang
1   School of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
2   Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints


Abstract

In our previous studies, Fenazinel has shown good neuroprotective effects; however, when Fenazinel entered phase 1 clinical trials, it was associated with certain side effects. This study aimed to explore novel neuroprotective agents with higher potency and lower toxicity. Evidence suggested that cinnamic acid and its analogs may serve as promising lead compounds for stroke treatment. In this study, a series of Fenazinel derivatives were first synthesized with potential neuroprotective effects with fragments including cinnamic acid and its analogs as key functional groups. The methyl thiazolyl tetrazolium assay was performed to assess the neuroprotective effects of the compounds in glutamate-induced neurotoxicity in SH-SY5Y cells. The hERG binding assay was conducted to assess drug-induced QT prolongation or other cardiotoxicity. The neuroprotective activity of the most potent compound in vivo was tested through the survival time of mice under the hypoxic condition and a middle cerebral artery occlusion model. Our data suggested that among those derivatives, compound 9d exhibited potent neuroprotective activity in vitro comparable to Fenazinel at the test concentrations. Significantly, 9d exhibited weak hERG inhibitory activity, showing moderate activities in both hypoxia-tolerant and MCAO models in vivo. Given the above, 9d has the potential for the treatment of stroke and could be considered a lead neuroprotective agent for further development.

Keywords

stroke - cinnamic acid - derivatives - hERG - neuroprotective

# These authors contributed equally to this work.




Publication History

Received: 28 October 2022

Accepted: 10 August 2023

Article published online:
12 September 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Reference

  • 1 Kunt R, Çınar BP, Yüksel B. et al. Clinical-epidemiological and radiological characteristics of stroke patients: a multicentre study. Int J Clin Pract 2021; 75 (12) e14963
    CrossrefPubMedSearch in Google Scholar
  • 2 Wu LQ. Pharmacologic treatment of ischemic stroke [in Chinese]. Prog Pharm Sci 2003; 27 (05) 303-306
    Search in Google Scholar
  • 3 Huber CC, Wang X, Wang H. Impact of cardiovascular diseases on ischemic stroke outcomes. J Integr Neurosci 2022; 21 (05) 138
    CrossrefPubMedSearch in Google Scholar
  • 4 Zhang QW, Jiang L, Wang G, Li JQ. Design, synthesis and neuroprotective effects of fenazinel derivatives. Chin Chem Lett 2017; 28 (07) 1505-1508
    CrossrefSearch in Google Scholar
  • 5 Li J, Huang L, Xia Y. Synthesis of aroylpiperazine derivatives and their anti-cerebral anoxia, anti-cerebral ischemia biological activities. Zhongguo Yaowu Huaxue Zazhi 2006; 16 (01) 6-14
    Search in Google Scholar
  • 6 Wang WY, Shen CW, Weng ZJ. et al. Design, synthesis and biological evaluation of novel dicarbonylalkyl piperazine derivatives as neuroprotective agents. Chin Chem Lett 2016; 27 (03) 387-390
    CrossrefSearch in Google Scholar
  • 7 Zhao T. Protective effects of fenazinel dihydrochloride against stroke in stroke-prone spontaneously hypertensive rats. Acad J Second Military Med Univ 2011; 1282-1285
    Search in Google Scholar
  • 8 Li D, Li J, Huang L. Protective effects of fenazinel dihydrochloride on focal cerebral ischemic injury in rats. Chin Pharmacol Bull 2009; 25: 716-720
    Search in Google Scholar
  • 9 Jin L, Sheng Y, Zhong Y, Zhu P, Xia Y. Relation between therapeutic effects and administration time of fenazinel dihydrochloride on focal cerebral ischemia injury in rats. Carol J Pharm 2008; 5: 356-358
    Search in Google Scholar
  • 10 Chen Y, Lu M, Zhang B, Xie B. Preparation of fenazinel dihydrochloride injection. Carol J Pharm 2007; 38 (12) 852-854
    Search in Google Scholar
  • 11 Recanatini M, Poluzzi E, Masetti M, Cavalli A, De Ponti F. QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development. Med Res Rev 2005; 25 (02) 133-166
    CrossrefPubMedSearch in Google Scholar
  • 12 Zhang X, He X, Chen Q, Lu J, Rapposelli S, Pi R. A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease. Bioorg Med Chem 2018; 26 (03) 543-550
    CrossrefPubMedSearch in Google Scholar
  • 13 Villareal MO, Sasaki K, Margout D. et al. Neuroprotective effect of Picholine virgin olive oil and its hydroxycinnamic acids component against β-amyloid-induced toxicity in SH-SY5Y neurotypic cells. Cytotechnology 2016; 68 (06) 2567-2578
    CrossrefPubMedSearch in Google Scholar
  • 14 Wang K, Shi J, Zhou Y. et al. Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease. Bioorg Chem 2021; 112: 104879
    CrossrefPubMedSearch in Google Scholar
  • 15 Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease. Drug Des Devel Ther 2015; 9: 5499-5510
    PubMedSearch in Google Scholar
  • 16 Yoon BH, Jung JW, Lee JJ. et al. Anxiolytic-like effects of sinapic acid in mice. Life Sci 2007; 81 (03) 234-240
    CrossrefPubMedSearch in Google Scholar
  • 17 Lee EH, Shin JH, Kim SS, Seo SR. Sinapic acid controls inflammation by suppressing nlrp3 inflammasome activation. Cells 2021; 10 (09) 2327
    CrossrefPubMedSearch in Google Scholar
  • 18 Płowuszyńska A, Gliszczyńska A. Recent developments in therapeutic and nutraceutical applications of p-methoxycinnamic acid from plant origin. Molecules 2021; 26 (13) 3827
    CrossrefPubMedSearch in Google Scholar
  • 19 Rychlicka M, Rot A, Gliszczyńska A. Biological properties, health benefits and enzymatic modifications of dietary methoxylated derivatives of cinnamic acid. Foods 2021; 10 (06) 1417
    CrossrefPubMedSearch in Google Scholar
  • 20 He L, Du JJ, Zhou JJ. et al. Synthesis of melatonin derivatives and the neuroprotective effects on parkinson's disease models of caenorhabditis elegans. Front Chem 2022; 10: 918116
    CrossrefPubMedSearch in Google Scholar
  • 21 Sevindik M, Akgul H, Selamoglu Z, Braidy N. Antioxidant, antimicrobial and neuroprotective effects of Octaviania asterosperma in vitro. Mycology 2020; 12 (02) 128-138
    CrossrefPubMedSearch in Google Scholar
  • 22 Zhang L, Wu Y, Yang G. et al. Design, synthesis and biological evaluation of novel osthole-based derivatives as potential neuroprotective agents. Bioorg Med Chem Lett 2020; 30 (24) 127633
    CrossrefPubMedSearch in Google Scholar
  • 23 Lu T, Liu Y, Liu Y. et al. Discovery, biological evaluation and molecular dynamic simulations of butyrylcholinesterase inhibitors through structure-based pharmacophore virtual screening. Future Med Chem 2021; 13 (09) 769-784
    CrossrefPubMedSearch in Google Scholar
  • 24 Cifuentes J, Salazar VA, Cuellar M. et al. Antioxidant and neuroprotective properties of non-centrifugal cane sugar and other sugarcane derivatives in an in vitro induced parkinson's model. Antioxidants 2021; 10 (07) 1040
    CrossrefPubMedSearch in Google Scholar
  • 25 Petrovic N, Tosti T, Srbljak I, Đurić A, Kosanic M. Chemical composition and bioctivity of the giant polypore or black-staining mushroom, meripilus giganteus (agaricomycetes), from serbia. Int J Med Mushrooms 2022; 24 (07) 21-40
    CrossrefPubMedSearch in Google Scholar
  • 26 Dubin AE, Nasser N, Rohrbacher J. et al. Identifying modulators of hERG channel activity using the PatchXpress planar patch clamp. J Biomol Screen 2005; 10 (02) 168-181
    CrossrefPubMedSearch in Google Scholar